Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FMYNN
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,479
Award facts
- Contract value 100% obligated
- $7,478.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,478.60 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count) on August 21, 2025, with a completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued through AmerisourceBergen's comprehensive global pharmaceutical support vehicle with the DLA, which enables the company to supply a wide range of medications and medical supplies to support military healthcare systems. Gemtesa (mirabegron) is a medication used to treat overactive bladder and represents the type of specialty pharmaceutical product that AmerisourceBergen regularly delivers through its federal contracts. The award reflects AmerisourceBergen's capability to fulfill federal medical supply requirements through open competition, as evidenced by its extensive portfolio of delivery orders across multiple therapeutic domains serving the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FMYNN?
SPE2DB25FMYNN was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FMYNN worth?
The government has obligated $7,479 on SPE2DB25FMYNN.
Is contract SPE2DB25FMYNN an order under another contract?
Yes. SPE2DB25FMYNN is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMYNN competed?
The extent of competition for SPE2DB25FMYNN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award